Tag: Fisher & Paykel Healthcare
F&P announces Walshe to participate in executive program
October 5, 2023HME News Staff
AUCKLAND, New Zealand – Fisher & Paykel Healthcare has selected Charlotte Walshe to participate in its Future Directors program, effective Jan. 1, 2024. Walshe has more than 20 years of experience across a range of sectors and has held chief executive roles with Jade Software and Dynamic Controls. "Charlotte’s experience and dynamism will be valuable assets," said Scott St. John, board chairman. "She has demonstrated leadership and expertise in both public and private sectors in R&D and...
F&P highlights mask performance in new guidanceÂ
September 12, 2023HME News Staff
AUCKLAND, New Zealand – Fisher & Paykel Healthcare expects operating revenue for the first half of the 2024 financial year, which ends Sept. 30, 2023, to be about $790 million, a 14% increase compared to the same period the previous year.
The company expects net profit after tax to be between $95 million and $105 million.
“For the first four months of the 2024 financial year, revenue from OSA masks was stronger, and revenue from hospital hardware was marginally...
In brief: Philips testing, F&P changes, Medline donationÂ
July 26, 2023HME News Staff
AMSTERDAM – Testing on the impact of ozone cleaning on the Philips System One and DreamStation Go sleep therapy devices shows volatile organic compounds and particulate matter emissions related to foam degradation are within the applicable safety limits and are unlikely to result in appreciable harm to health in patients, the company announced July 24.
Additional visual assessments on used/returned first-generation DreamStation devices also confirmed the previously established low...
F&P Healthcare changes up boardÂ
July 24, 2023HME News Staff
AUCKLAND, New Zealand – Fisher & Paykel Healthcare has announced that Donal O’Dwyer will retire as director of the company effective Dec. 31, 2023. The company has also announced that it has appointed Graham McLean to the board as a non-executive director effective Oct. 1, 2023. “With Donal preparing to step away, we are very pleased to have secured Graham as a director,” said Scott St John, board chair. “Similar to Donal, Graham has carved out a successful global career...
F&P sticks with mask-first model
May 31, 2023Liz Beaulieu, Editor
AUCKLAND, New Zealand – Fisher & Paykel Healthcare’s mask revenue was up 28%, or 24% in constant currency, in the second half of the company’s 2023 fiscal year compared to the same period last year, thanks to a boost from its well-received Evora Full mask.
F&P launched Evora in May 2022 in the United States.
“It’s been a significant contributor to mask revenue,” said Lewis Gradon, CEO, during a call to discuss the company’s latest financial...
In brief: AdaptHealth settlement, Quipt raise, KabaFusion investment
April 28, 2023HME News Staff
PHILADELPHIA – AdaptHealth will pay $5.3 million to resolve alleged False Claims Act violations for submitting allegedly false claims to federal health care programs for respiratory devices that patients did not need or use, according to the U.S. Attorney’s Office for the Eastern District of Pennsylvania.
The settlement resolves allegations that between 2013 and 2017 AdaptHealth, known at the time as QMES and Tri-County Medical Equipment and Supply, knowingly and willfully billed...
In brief: F&P’s expectations, insulin affordability, Power 500 list
January 27, 2023HME News Staff
AUCKLAND, New Zealand – Fisher & Paykel Healthcare expects full year operating revenue for the 2023 financial year to be within the range of about $1.55 billion to $1.6 billion, the company announced on Jan. 19.
In F&P’s Homecare Product Group, sales of obstructive sleep apnea masks have remained strong, said Lewis Gradon, managing director and CEO.
“Our mask sales growth rate is currently tracking above that of our first half as global supply of CPAP hardware...
F&P: Mask sales have remained strong
January 23, 2023HME News Staff
AUCKLAND, New Zealand – Fisher & Paykel Healthcare expects full year operating revenue for the 2023 financial year to be within the range of about $1.55 billion to $1.6 billion, the company announced on Jan. 19.
In F&P’s Homecare Product Group, sales of obstructive sleep apnea masks have remained strong, said Lewis Gradon, managing director and CEO.
“Our mask sales growth rate is currently tracking above that of our first half as global supply of CPAP hardware...
F&P sees ‘a lot of drivers’ for growth in home care
December 2, 2022Liz Beaulieu, Editor
AUCKLAND, New Zealand – Fisher & Paykel Healthcare’s Homecare Product Group was a bright spot in the company’s financial results for the first half of the 2023 financial year, with revenue up 10% over the prior comparable period.
Revenue for OSA masks and accessories, specifically, increased 16% on the back of the positive reception to F&P’s new Evora Full. The mask, which features a floating seal and stability wings, received 510(k) clearance from the U.S. Food and...
F&P Healthcare reports double-digit decreases
November 29, 2022HME News Staff
AUCKLAND, New Zealand – Fisher & Paykel Healthcare reported a 23% decline in operating revenue to $690.6 million for the first half of the 2023 financial year.
The company pointed out, however, that this was more than the $670 million guided in an August trading update and a 21% increase on the comparable pre-pandemic period.
“Consistent with what we signaled in August, first half revenue was down on the prior corresponding period, as we lapped significant COVID-19-driven...